Skip to content
  • Home
  • Contact Us
  • Sitemap
  • Home
  • Contact Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 2, 2024

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More »

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More »

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More »

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More »

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More »

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More »
Page1 Page2 Page3 … Page7
RECENT POSTS

AI Integration in European Health Services Reaches 74% Adoption Rate

April 20, 2026

DRC Urban Trees Identified as Significant CO2 Sinks

April 5, 2026

The Africa We Build Summit Sets Sights on Mobilising Domestic Capital for Industrial Transformation

March 30, 2026

African Football Chief Motsepe to Respect CAS Ruling on Senegal’s Appeal

March 29, 2026

Republic of Congo Presidential Election Sees Sassou NGuesso Poised for Fifth Consecutive Term

March 15, 2026

Africa’s Role in Global Decision-Making Emphasized at African Union Summit

February 16, 2026
ADVERTISEMENT
Copyright © 2026 Le Congo Tribune. All Rights Reserved.